Symbol="VIR"
AssetType="Common Stock"
Name="Vir Biotechnology Inc"
Description="Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California."
CIK="1706431"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1736342000"
EBITDA="-255975008"
PERatio="None"
PEGRatio="None"
BookValue="13.49"
DividendPerShare="0"
DividendYield="0"
EPS="-1.07"
RevenuePerShareTTM="3.68"
ProfitMargin="-0.534"
OperatingMarginTTM="-0.55"
ReturnOnAssetsTTM="-0.0694"
ReturnOnEquityTTM="-0.139"
RevenueTTM="490721000"
GrossProfitTTM="1032030000"
DilutedEPSTTM="-1.07"
QuarterlyEarningsGrowthYOY="0.585"
QuarterlyRevenueGrowthYOY="-0.949"
AnalystTargetPrice="36.25"
TrailingPE="-"
ForwardPE="4.361"
PriceToSalesRatioTTM="1.409"
PriceToBookRatio="1.604"
EVToRevenue="0.52"
EVToEBITDA="0.789"
Beta="0.127"
num_52WeekHigh="31.55"
num_52WeekLow="12.56"
num_50DayMovingAverage="22.04"
num_200DayMovingAverage="24.47"
SharesOutstanding="133977000"
DividendDate="None"
ExDividendDate="None"
symbol="VIR"
open="13.50"
high="13.51"
low="12.91"
price="12.96"
volume="1732941.00"
latest_trading_day="2023-08-07"
previous_close="13.62"
change="-0.66"
change_percent="-4.8458%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="70"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="30"
Volume_recent_avg="1083703"
Change_recent_avg="0.02"
Delta_recent_avg="0.78"
Variance_recent_avg="0.39"
Change_ratio_recent_avg="0.02"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="30"
Aroon_momentum_negative="70"
image_negative_thumbnail_id_1="1102"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0135.jpeg"
image_negative_thumbnail_id_2="157"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0019.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="523"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_positive_thumbnail_id_1="964"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0126.jpeg"
image_positive_thumbnail_id_2="976"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
